# Prospective Study on the Feasibility of Plasma FLT3-Ligand Assay to Achieve a First Estimate of Its Prognostic Value on the Outcome of Patients Treated Intensively for Acute Leukemia

> **NCT02693899** · — · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 80 (actual)

## Conditions studied

- Acute Leukemia

## Interventions

- **OTHER:** Non Interventional study

## Key facts

- **NCT ID:** NCT02693899
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-27
- **Primary completion:** 2018-02-06
- **Final completion:** 2018-12-11
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02693899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02693899, "Prospective Study on the Feasibility of Plasma FLT3-Ligand Assay to Achieve a First Estimate of Its Prognostic Value on the Outcome of Patients Treated Intensively for Acute Leukemia". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT02693899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*